GPX2 and pancreatic neoplasm: The only exceptions were (i) GPX2, whose high expression levels correlated with OS in breast and head and neck cancers; and (ii) TXNRD1, whose high expression levels correlated with poor OS in head and neck, kidney, liver, and pancreas cancers.